Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serva

Showing results (231-240 of 246) with videos related to

Pageof 25
Sort By:
Scientific Reports|September 11, 2021
Oral hygiene and oral microbiota in children and young people with neurological impairment and oropharyngeal dysphagiaLuiz Fernando Fregatto, Isabela Bazzo Costa, Daniel De Bortoli Teixeira, et al.
BMC Biology|September 11, 2023
Diversity of RNA viruses in the cosmopolitan monoxenous trypanosomatid Leptomonas pyrrhocorisDiego H Macedo, Danyil Grybchuk, Jana Režnarová, et al.
Ocular Immunology and Inflammation|September 25, 2020
Ocular Disease in Mice Inoculated with Pork Heart Samples Infected with <i>Toxoplasma gondii</i>Deise F Costa, Rafael Pedro Madeira, Ana Claudia Torrecilhas, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterizationDanielle Gully, Michel Geslin, Laurence Serva, et al.
Journal of Neurology|January 15, 2020
Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohortEdgar Carnero Contentti, Vanessa Daccach Marques, Ibis Soto de Castillo, et al.
Nucleic Acids Research|September 20, 2013
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell linesKathleen Börner, Dominik Niopek, Gabriella Cotugno, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2017
Viral discovery and diversity in trypanosomatid protozoa with a focus on relatives of the human parasite <i>Leishmania</i>Danyil Grybchuk, Natalia S Akopyants, Alexei Y Kostygov, et al.
Pharmaceutics|June 2, 2021
Osseointegration Improvement of Co-Cr-Mo Alloy Produced by Additive ManufacturingAmilton Iatecola, Guilherme Arthur Longhitano, Luiz Henrique Martinez Antunes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2019
Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patientsEdgar Carnero Contentti, Vanessa Daccach Marques, Ibis Soto de Castillo, et al.
Multiple Sclerosis and Related Disorders|April 7, 2020
Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American populationFacundo Silveira, Agustín Pappolla, Francisco Sánchez, et al.
Pageof 25

Showing results (231-240 of 246) with videos related to

Sort By:
Pageof 25
Scientific Reports|September 11, 2021
Oral hygiene and oral microbiota in children and young people with neurological impairment and oropharyngeal dysphagiaLuiz Fernando Fregatto, Isabela Bazzo Costa, Daniel De Bortoli Teixeira, et al.
BMC Biology|September 11, 2023
Diversity of RNA viruses in the cosmopolitan monoxenous trypanosomatid Leptomonas pyrrhocorisDiego H Macedo, Danyil Grybchuk, Jana Režnarová, et al.
Ocular Immunology and Inflammation|September 25, 2020
Ocular Disease in Mice Inoculated with Pork Heart Samples Infected with <i>Toxoplasma gondii</i>Deise F Costa, Rafael Pedro Madeira, Ana Claudia Torrecilhas, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterizationDanielle Gully, Michel Geslin, Laurence Serva, et al.
Journal of Neurology|January 15, 2020
Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohortEdgar Carnero Contentti, Vanessa Daccach Marques, Ibis Soto de Castillo, et al.
Nucleic Acids Research|September 20, 2013
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell linesKathleen Börner, Dominik Niopek, Gabriella Cotugno, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2017
Viral discovery and diversity in trypanosomatid protozoa with a focus on relatives of the human parasite <i>Leishmania</i>Danyil Grybchuk, Natalia S Akopyants, Alexei Y Kostygov, et al.
Pharmaceutics|June 2, 2021
Osseointegration Improvement of Co-Cr-Mo Alloy Produced by Additive ManufacturingAmilton Iatecola, Guilherme Arthur Longhitano, Luiz Henrique Martinez Antunes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2019
Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patientsEdgar Carnero Contentti, Vanessa Daccach Marques, Ibis Soto de Castillo, et al.
Multiple Sclerosis and Related Disorders|April 7, 2020
Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American populationFacundo Silveira, Agustín Pappolla, Francisco Sánchez, et al.
Pageof 25